1. Home
  2. XWEL vs ENVB Comparison

XWEL vs ENVB Comparison

Compare XWEL & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XWEL

XWELL Inc.

N/A

Current Price

$0.41

Market Cap

5.9M

ML Signal

N/A

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

N/A

Current Price

$1.41

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XWEL
ENVB
Founded
2006
1994
Country
United States
United States
Employees
N/A
6
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
6.4M
IPO Year
2010
2000

Fundamental Metrics

Financial Performance
Metric
XWEL
ENVB
Price
$0.41
$1.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 33.3K
27.5K
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$29,210,000.00
★ $39,914,675.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.26
$1.17
52 Week High
$2.20
$795.00

Technical Indicators

Market Signals
Indicator
XWEL
ENVB
Relative Strength Index (RSI) 23.65 44.66
Support Level $0.33 $1.35
Resistance Level $0.50 $1.55
Average True Range (ATR) 0.07 0.09
MACD -0.01 -0.00
Stochastic Oscillator 31.60 22.73

Price Performance

Historical Comparison
XWEL
ENVB

About XWEL XWELL Inc.

XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: